Active, not recruitingPhase 2NCT02968212

Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)

Studying Pulmonary non-tuberculous mycobacterial infection

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oregon Health and Science University
Principal Investigator
Kevin Winthrop, MD
Oregon Health and Science University
Intervention
Clofazimine(drug)
Enrollment
102 enrolled
Eligibility
18 years · All sexes
Timeline
20172026

Study locations (7)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · National Jewish Health · The University of Texas Health Science Center at Tyler · National Institute of Allergy and Infectious Diseases (NIAID) · University of Chicago · Temple University · University of South Florida

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02968212 on ClinicalTrials.gov

Other trials for Pulmonary non-tuberculous mycobacterial infection

Additional recruiting or active studies for the same condition.

See all trials for Pulmonary non-tuberculous mycobacterial infection

← Back to all trials